Literature DB >> 18820993

Power Doppler ultrasonography with time-signal intensity curves in monitoring hepatocellular carcinoma and liver metastases after intralesional therapy.

R Farina1, F Pennisi, G Mazzone, M Pennisi, G Riva, P V Foti, C Puglisi, G C Ettorre.   

Abstract

PURPOSE: Analysis of time-intensity curves allows evaluation of the patterns of lesion enhancement before and after treatment. The aim of this study was to evaluate the diagnostic accuracy of time-intensity curves in monitoring intralesional therapy of focal hepatic lesions.
MATERIALS AND METHODS: Twenty patients underwent intralesional therapy with either radiofrequency thermal ablation or percutaneous ethanol injection. Contrast-enhanced power Doppler ultrasound with analysis of time-intensity curves was performed one day before and one day after treatment. Targeted biopsy was then obtained to confirm the imaging findings.
RESULTS: Before treatment, all lesions showed time-intensity curves characterised by high peaks of signal intensity and plateaus. Complete tumour necrosis, confirmed by targeted biopsy, was observed in patients showing no intralesional flow signals and time-intensity curves with low peak of signal intensity and absence of plateau after treatment. Biopsy confirmed the presence of residual neoplastic tissue in one patient exhibiting perilesional vascularity, absence of intralesional flow signals, and a time-intensity curve with high peak of signal intensity and plateau.
CONCLUSIONS: According to our findings, time-intensity curves characterised by high peak of signal intensity and plateau might reflect the presence of perilesional or intralesional neoplastic tissue and provide important information on the effectiveness of the treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18820993     DOI: 10.1007/s11547-008-0324-z

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  23 in total

Review 1.  [Long-term results of chemoembolization for hepatocarcinoma].

Authors:  G P Feltrin; S Savastano; A Marangon; D Miotto; M Chiesura-Corona
Journal:  Radiol Med       Date:  1997 Jul-Aug       Impact factor: 3.469

2.  Radiofrequency ablation for hepatocellular carcinoma and metastatic liver tumors: a comparative study.

Authors:  Danny H F Chow; Lorraine H Y Sinn; Kelvin K Ng; Chi Ming Lam; Jimmy Yuen; Sheung Tat Fan; Ronnie T P Poon
Journal:  J Surg Oncol       Date:  2006-12-01       Impact factor: 3.454

3.  Phase-inversion sonography during the liver-specific late phase of contrast enhancement: improved detection of liver metastases.

Authors:  T Albrecht; C W Hoffmann; S A Schmitz; S Schettler; A Overberg; C T Germer; K J Wolf
Journal:  AJR Am J Roentgenol       Date:  2001-05       Impact factor: 3.959

4.  Ethanol versus radiofrequency ablation for the treatment of small hepatocellular carcinoma in patients with cirrhosis: a retrospective study of efficacy and cost.

Authors:  Olivier Seror; Gisèle N'Kontchou; Myint Tin Tin Htar; Isabelle Durand-Zaleski; Jean Claude Trinchet; Nicolas Sellier; Michel Beaugrand
Journal:  Gastroenterol Clin Biol       Date:  2006-11

5.  Signal intensity of the liver parenchyma in microbubble contrast agent in the late liver phase reflects advanced fibrosis of the liver.

Authors:  Tetsuya Kaneko; Osamu Teshigawara; Hiroyuki Sugimoto; Masashi Hirota; Soichiro Inoue; Shin Takeda; Akimasa Nakao
Journal:  Liver Int       Date:  2005-04       Impact factor: 5.828

6.  Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: Ethanol injection therapy and radiofrequency ablation.

Authors:  Masao Omata; Ryosuke Tateishi; Haruhiko Yoshida; Shuichiro Shiina
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

7.  Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging.

Authors:  Chan Kyo Kim; Dongil Choi; Hyo K Lim; Seung Hoon Kim; Won Jae Lee; Min Ju Kim; Ji Yeon Lee; Yong Hwan Jeon; Jongmee Lee; Soon Jin Lee; Jae Hoon Lim
Journal:  Eur J Radiol       Date:  2005-10       Impact factor: 3.528

8.  [Combined treatment of hepatocarcinoma with chemoembolization and alcohol administration. Long-term results].

Authors:  C Bartolozzi; R Lencioni; N Armillotta
Journal:  Radiol Med       Date:  1997 Jul-Aug       Impact factor: 3.469

9.  Ultrasound-guided percutaneous thermal ablation of hepatocellular carcinoma using microwave and radiofrequency ablation.

Authors:  H-X Xu; X-Y Xie; M-D Lu; J-W Chen; X-Y Yin; Z-F Xu; G-J Liu
Journal:  Clin Radiol       Date:  2004-01       Impact factor: 2.350

10.  Role of contrast-enhanced color Doppler ultrasonography and dynamic flow in the evaluation of hepatic tumors treated with radiofrequency.

Authors:  N Lassau; M Lamuraglia; I Chawi; T Smayra; C Dromain; S Koscielny; T de Baere; J Leclère; A Roche
Journal:  Cancer Imaging       Date:  2005-05-25       Impact factor: 3.909

View more
  1 in total

Review 1.  Functional imaging of hepatocellular carcinoma.

Authors:  Tim Ch Hoogenboom; Mark Thursz; Eric O Aboagye; Rohini Sharma
Journal:  Hepat Oncol       Date:  2016-03-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.